Standard BioTools Inc. (LAB)
NASDAQ: LAB · Real-Time Price · USD
1.115
+0.095 (9.31%)
May 8, 2025, 4:00 PM EDT - Market closed
Standard BioTools Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 169.69 | 174.43 | 106.34 | 97.95 | 128.85 | 131.39 | Upgrade
|
| Other Revenue | - | - | - | - | 1.73 | 6.76 | Upgrade
|
| Revenue | 169.69 | 174.43 | 106.34 | 97.95 | 130.58 | 138.14 | Upgrade
|
| Revenue Growth (YoY) | 33.86% | 64.03% | 8.57% | -24.99% | -5.47% | 17.83% | Upgrade
|
| Cost of Revenue | 89.87 | 90.17 | 55.89 | 60.9 | 99.15 | 91.28 | Upgrade
|
| Gross Profit | 79.82 | 84.26 | 50.45 | 37.05 | 31.43 | 46.87 | Upgrade
|
| Selling, General & Admin | 148.37 | 156.61 | 87.54 | 102.29 | 98.89 | 97.9 | Upgrade
|
| Research & Development | 57.76 | 62.41 | 25.95 | 33.86 | - | - | Upgrade
|
| Operating Expenses | 206.13 | 219.02 | 113.49 | 136.14 | 98.89 | 97.9 | Upgrade
|
| Operating Income | -126.32 | -134.76 | -63.04 | -99.09 | -67.46 | -51.04 | Upgrade
|
| Interest Expense | -2.29 | -3.32 | -4.57 | -4.33 | -3.82 | -3.57 | Upgrade
|
| Interest & Investment Income | 16.91 | 20.2 | 5.57 | 2.23 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.93 | -5.17 | 1.39 | -60.9 | 7.62 | 0.51 | Upgrade
|
| EBT Excluding Unusual Items | -110.76 | -123.05 | -60.64 | -162.09 | -63.66 | -54.1 | Upgrade
|
| Merger & Restructuring Charges | -21.71 | -40.48 | -13.56 | -13.59 | - | - | Upgrade
|
| Asset Writedown | - | - | - | -3.53 | - | - | Upgrade
|
| Other Unusual Items | - | 25.21 | - | -13.72 | - | - | Upgrade
|
| Pretax Income | -132.47 | -138.31 | -74.2 | -192.93 | -63.66 | -54.1 | Upgrade
|
| Income Tax Expense | 0.29 | 0.57 | 0.45 | -2.83 | -4.42 | -1.08 | Upgrade
|
| Net Income | -132.76 | -138.89 | -74.66 | -190.1 | -59.24 | -53.02 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | 46.01 | - | - | - | - | Upgrade
|
| Net Income to Common | -132.76 | -184.9 | -74.66 | -190.1 | -59.24 | -53.02 | Upgrade
|
| Shares Outstanding (Basic) | 374 | 353 | 79 | 78 | 76 | 72 | Upgrade
|
| Shares Outstanding (Diluted) | 374 | 353 | 79 | 78 | 76 | 72 | Upgrade
|
| Shares Change (YoY) | 181.57% | 346.24% | 1.09% | 3.32% | 5.19% | 7.88% | Upgrade
|
| EPS (Basic) | -0.35 | -0.52 | -0.94 | -2.43 | -0.78 | -0.74 | Upgrade
|
| EPS (Diluted) | -0.35 | -0.52 | -0.94 | -2.43 | -0.78 | -0.74 | Upgrade
|
| Free Cash Flow | -123.89 | -151.81 | -46.12 | -93.2 | -57.33 | -28.13 | Upgrade
|
| Free Cash Flow Per Share | -0.33 | -0.43 | -0.58 | -1.19 | -0.76 | -0.39 | Upgrade
|
| Gross Margin | 47.04% | 48.31% | 47.44% | 37.83% | 24.07% | 33.92% | Upgrade
|
| Operating Margin | -74.44% | -77.25% | -59.28% | -101.17% | -51.66% | -36.94% | Upgrade
|
| Profit Margin | -78.24% | -106.00% | -70.20% | -194.08% | -45.36% | -38.38% | Upgrade
|
| Free Cash Flow Margin | -73.01% | -87.03% | -43.37% | -95.15% | -43.90% | -20.37% | Upgrade
|
| EBITDA | -110.48 | -117.9 | -47.86 | -84.06 | -63.81 | -47.02 | Upgrade
|
| EBITDA Margin | -65.11% | -67.59% | -45.01% | -85.82% | -48.86% | -34.04% | Upgrade
|
| D&A For EBITDA | 15.84 | 16.86 | 15.18 | 15.03 | 3.65 | 4.01 | Upgrade
|
| EBIT | -126.32 | -134.76 | -63.04 | -99.09 | -67.46 | -51.04 | Upgrade
|
| EBIT Margin | -74.44% | -77.25% | -59.28% | -101.17% | -51.66% | -36.94% | Upgrade
|
| Revenue as Reported | 169.69 | 174.43 | 106.34 | 97.95 | 130.58 | 138.14 | Upgrade
|
| Advertising Expenses | - | 5.9 | 2 | - | 3.4 | 1.6 | Upgrade
|
Updated May 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.